These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24048401)

  • 41. Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment.
    Pariante CM; Miller AH
    Biol Psychiatry; 2001 Mar; 49(5):391-404. PubMed ID: 11274650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Targets of anti-glucocorticoid therapy for stress-related diseases.
    Martocchia A; Stefanelli M; Falaschi GM; Toussan L; Rocchietti March M; Raja S; Romano G; Falaschi P
    Recent Pat CNS Drug Discov; 2013 Apr; 8(1):79-87. PubMed ID: 23489288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuroactive steroids modulate HPA axis activity and cerebral brain-derived neurotrophic factor (BDNF) protein levels in adult male rats.
    Naert G; Maurice T; Tapia-Arancibia L; Givalois L
    Psychoneuroendocrinology; 2007; 32(8-10):1062-78. PubMed ID: 17928160
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Not fade away: the HPA axis and depression.
    Cowen PJ
    Psychol Med; 2010 Jan; 40(1):1-4. PubMed ID: 19335939
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Glucocorticoid receptor polymorphisms in major depression.
    Claes S
    Ann N Y Acad Sci; 2009 Oct; 1179():216-28. PubMed ID: 19906242
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic syndrome, activity of the hypothalamic-pituitary-adrenal axis and inflammatory mediators in depressive disorder.
    Martinac M; Pehar D; Karlović D; Babić D; Marcinko D; Jakovljević M
    Acta Clin Croat; 2014 Mar; 53(1):55-71. PubMed ID: 24974667
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurogenesis along the septo-temporal axis of the hippocampus: are depression and the action of antidepressants region-specific?
    Tanti A; Belzung C
    Neuroscience; 2013 Nov; 252():234-52. PubMed ID: 23973415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do antidepressants regulate how cortisol affects the brain?
    Pariante CM; Thomas SA; Lovestone S; Makoff A; Kerwin RW
    Psychoneuroendocrinology; 2004 May; 29(4):423-47. PubMed ID: 14749091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance.
    Juruena MF; Pariante CM; Papadopoulos AS; Poon L; Lightman S; Cleare AJ
    Br J Psychiatry; 2009 Apr; 194(4):342-9. PubMed ID: 19336786
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antidepressant-like activity of a Kampo (Japanese herbal) medicine, Koso-san (Xiang-Su-San), and its mode of action via the hypothalamic-pituitary-adrenal axis.
    Ito N; Nagai T; Yabe T; Nunome S; Hanawa T; Yamada H
    Phytomedicine; 2006 Nov; 13(9-10):658-67. PubMed ID: 16516452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Persistent effects of mifepristone (RU-486) on cortisol levels in bipolar disorder and schizophrenia.
    Gallagher P; Watson S; Elizabeth Dye C; Young AH; Nicol Ferrier I
    J Psychiatr Res; 2008 Oct; 42(12):1037-41. PubMed ID: 18255098
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment.
    Calfa G; Kademian S; Ceschin D; Vega G; Rabinovich GA; Volosin M
    Psychoneuroendocrinology; 2003 Jul; 28(5):687-701. PubMed ID: 12727135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of anxiolytic and antidepressant drugs with hormones of the hypothalamic-pituitary-adrenal axis.
    File SE
    Pharmacol Ther; 1990; 46(3):357-75. PubMed ID: 1971443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of genetically altered brain glucocorticoid receptor action on behavior and adrenal axis regulation in mice.
    Howell MP; Muglia LJ
    Front Neuroendocrinol; 2006 Sep; 27(3):275-84. PubMed ID: 16814372
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The 5-HT receptor--G-protein--effector system complex in depression. I. Effect of glucocorticoids.
    Lesch KP; Lerer B
    J Neural Transm Gen Sect; 1991; 84(1-2):3-18. PubMed ID: 1647169
    [TBL] [Abstract][Full Text] [Related]  

  • 56. GILZ: Glitzing up our understanding of the glucocorticoid receptor in psychopathology.
    Thiagarajah AS; Eades LE; Thomas PR; Guymer EK; Morand EF; Clarke DM; Leech M
    Brain Res; 2014 Jul; 1574():60-9. PubMed ID: 24931768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Research on the Pathological Mechanism and Drug Treatment Mechanism of Depression.
    Peng GJ; Tian JS; Gao XX; Zhou YZ; Qin XM
    Curr Neuropharmacol; 2015; 13(4):514-23. PubMed ID: 26412071
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vasopressin in health and disease with a focus on affective disorders.
    Zelena D
    Cent Nerv Syst Agents Med Chem; 2012 Dec; 12(4):286-303. PubMed ID: 22954353
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antidepressant and other centrally acting drugs regulate glucocorticoid receptor messenger RNA levels in rat brain.
    Peiffer A; Veilleux S; Barden N
    Psychoneuroendocrinology; 1991; 16(6):505-15. PubMed ID: 1811246
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The glucocorticoid receptor: part of the solution or part of the problem?
    Pariante CM
    J Psychopharmacol; 2006 Jul; 20(4 Suppl):79-84. PubMed ID: 16785275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.